Relation Therapeutics

Relation Therapeutics is an end-to-end AI-driven biotech company developing transformational medicines for genetically-defined diseases. The company's ambition is to understand human biology in an unprecedented way by leveraging single-cell multi-omics data directly from patient tissue, functional assays, and machine learning — driving drug discovery from cause to cure. Its Lab-in-the-Loop platform seamlessly integrates single-cell analysis, genomics, and machine learning to select druggable targets and advance novel therapeutics. Led by experienced drug developers, computational scientists, and entrepreneurs from biotech, pharma, venture, and academia, Relation has established strategic collaborations with Novartis to advance therapeutics for atopic diseases, and with Deerfield Management to form new companies from discovered drug targets. The company is headquartered in London and has raised over $40 million in funding.